Therapeutic potential of GLP-1 Agonists for Hidradenitis Suppurativa

International Journal of DermatologyVolume 62, Issue 12 p. 1543-1544 Commentary Therapeutic potential of GLP-1 agonists for hidradenitis suppurativa Tanya Henry, Tanya Henry University of Illinois, College of Medicine, Chicago, IL, USASearch for more papers by this authorBrian Cahn MD, Corresponding Author Brian Cahn MD [email protected] Department of Dermatology, University of Illinois, Chicago, IL, USA Correspondence Brian Cahn, md Department of Dermatology University of Illinois 808 S Wood St Chicago, IL 60612 USA E-mail: [email protected]Search for more papers by this authorRoger Haber MD, Roger Haber MD Department of Dermatology, University of Illinois, Chicago, IL, USASearch for more papers by this authorJohn T. Landers MD, John T. Landers MD Lovell Federal Health Care Center, North Chicago, IL, USASearch for more papers by this authorReed Berger-Fleishman MD, PNS, Reed Berger-Fleishman MD, PNS Department of Bariatric Surgery, University of Illinois, Chicago, IL, USASearch for more papers by this authorMurad Alam MD, Murad Alam MD Department of Dermatology, Northwestern Medicine, Chicago, Illinois, USASearch for more papers by this authorSheryl Hoyer MD, Sheryl Hoyer MD Department of Dermatology, University of Illinois, Chicago, IL, USASearch for more papers by this author Tanya Henry, Tanya Henry University of Illinois, College of Medicine, Chicago, IL, USASearch for more papers by this authorBrian Cahn MD, Corresponding Author Brian Cahn MD [email protected] Department of Dermatology, University of Illinois, Chicago, IL, USA Correspondence Brian Cahn, md Department of Dermatology University of Illinois 808 S Wood St Chicago, IL 60612 USA E-mail: [email protected]Search for more papers by this authorRoger Haber MD, Roger Haber MD Department of Dermatology, University of Illinois, Chicago, IL, USASearch for more papers by this authorJohn T. Landers MD, John T. Landers MD Lovell Federal Health Care Center, North Chicago, IL, USASearch for more papers by this authorReed Berger-Fleishman MD, PNS, Reed Berger-Fleishman MD, PNS Department of Bariatric Surgery, University of Illinois, Chicago, IL, USASearch for more papers by this authorMurad Alam MD, Murad Alam MD Department of Dermatology, Northwestern Medicine, Chicago, Illinois, USASearch for more papers by this authorSheryl Hoyer MD, Sheryl Hoyer MD Department of Dermatology, University of Illinois, Chicago, IL, USASearch for more papers by this author First published: 28 October 2023 https://doi.org/10.1111/ijd.16892 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Amat-Samaranch V, Agut-Busquet E, Vilarrasa E, Puig L. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2021; 12:204062232110559. https://doi.org/10.1177/20406223211055920 10.1177/20406223211055920 Web of Science®Google Scholar 2 Novo Nordisk Inc. Victoza. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022341s027lbl.pdf. Revised August 2017. Accessed April 17, 2023. Google Scholar 3Astrup A, Rössner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009; 374(9701): 1606–1616. 10.1016/S0140-6736(09)61375-1 CASPubMedWeb of Science®Google Scholar 4 Novo Nordisk Inc. Wegovy. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf#page=26. Revised June 2021. Accessed April 17,2023. Google Scholar 5Collins L, Costello RA. Glucagon-like peptide-1 receptor agonists. StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Google Scholar Volume62, Issue12December 2023Pages 1543-1544 ReferencesRelatedInformation